Burns v. Copley Pharmaceuticals, Inc.
This text of 132 F.3d 42 (Burns v. Copley Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.
Opinion
132 F.3d 42
97 CJ C.A.R. 3307
NOTICE: Although citation of unpublished opinions remains unfavored, unpublished opinions may now be cited if the opinion has persuasive value on a material issue, and a copy is attached to the citing document or, if cited in oral argument, copies are furnished to the Court and all parties. See General Order of November 29, 1993, suspending 10th Cir. Rule 36.3 until December 31, 1995, or further order.
In re COPLEY PHARMACEUTICAL, INC., "Albuterol" Products
Liability Litigation.
James BURNS and Vickie Burns, personally and as parents and
guardians of Jimmy Burns, Plaintiffs-Appellants,
v.
COPLEY PHARMACEUTICAL, INC., Defendant-Appellee,
and
NATIONAL PHARMACIES, INC., Defendant.
No. 96-8054.
(D.C. No. 94-MDL-1013 & 96-1601-MDL) (D.Wyo.).
United States Court of Appeals, Tenth Circuit.
Dec. 11, 1997.
Before PORFILIO and LUCERO, C.JJ., and MARTEN,** D.J.
ORDER AND JUDGMENT*
MARTEN, D.J.
After examining the briefs and appellate record, this panel has determined unanimously to grant the parties' request for a decision on the briefs without oral argument. See Fed. R.App. P. 34(f) and 10th Cir. R. 34.1.9. The case is therefore ordered submitted without oral argument.
Plaintiffs-appellants James and Vickie Burns (the Burnses) seek review of an order of the district court denying their untimely motion to opt out of a multidistrict class action against defendant-appellee Copley Pharmaceutical, Inc., the manufacturer of a prescription drug, albuterol sulfate inhalation solution (albuterol). The Burnses had filed an individual lawsuit, alleging that Copley and National Pharmacies, Inc., a seller of albuterol, are liable for the death of their child. We reverse and remand for additional findings.
BACKGROUND
The Burnses filed their action on November 1, 1995, in South Carolina state court. At the time, Copley was the defendant in numerous other lawsuits, initiated after it had announced a voluntary recall of batches of contaminated albuterol. Previously, the judicial panel for multi-district litigation had consolidated the federal cases brought against Copley in the United States District Court for the District of Wyoming. On October 28, 1994, that court had certified the multi-district action as a Fed.R.Civ.P. 23(b)(3) class action of "[a]ll persons throughout the United States and its territories who suffered damages as a result of the inhalation of Albuterol manufactured, supplied, distributed or placed in commerce by Copley Pharmaceutical, Inc." In re Copley Pharm., Inc., ("Albuterol" Prod. Liability Litig.), 158 F.R.D. 485, 493 (D.Wyo.1994).1
Class counsel was ordered to give notice of the action by direct mail to potential class members known to Copley2 and class counsel, and by publication in USA Today and speciality magazines. The district court set the opt-out deadline of March 15, 1995. The parties reached a settlement on August 22, 1995, which the court preliminarily approved on August 28, 1995.
The following month, the Burnses learned of the class action from a physician who was treating their child. After contacting attorneys, they filed a motion to opt out of the class on October 20, 1995, and commenced their action in state court. The case was removed to federal court and included in the class action. On November 15, 1995, the district court entered an order finally approving the class action settlement. It did not enter the final order of dismissal required by the agreement3 and retained jurisdiction to administer the agreement. On May 3, 1996, the district court denied the Burnses' motion to opt out, and allowed them thirty days to file a proof of claim. Rather than proceeding with their claim in the class action, the Burnses filed this appeal.
DISCUSSION
A. Jurisdiction
We first examine whether we have jurisdiction over this appeal, in light of the lack of a dismissal order and the district court's continuing administration of the settlement. As we have previously explained, under 28 U.S.C. § 1291,
we have jurisdiction only over "final" decisions of the district court; that is, those decisions that leave nothing for the court to do but execute the judgment. Notably, a decision "final" within the meaning of § 1291 does not necessarily mean the last order possible to be made in a case. Thus, a district court's decision is appealable if it falls within "that small class which finally determine claims of right separable from, and collateral to, rights asserted in the action, too important to be denied review and too independent of the cause itself to require that appellate consideration be deferred until the whole case is adjudicated." Cohen v. Beneficial Industrial Loan Corp., 337 U.S. 541, 546 (1949).
To come within Cohen's collateral order doctrine, an order must conclusively determine the disputed question, resolve an important issue completely separate from the merits of the action, and be effectively unreviewable on appeal from a final judgment.
Myers v. Oklahoma County Bd. of County Comm'rs, 80 F.3d 421, 425 (10th Cir.), cert. denied, 117 S.Ct. 383 (1996) (further citations and quotations omitted).
The circumstances of this case meet all three of the requirements of the collateral order doctrine. The denial of the motion to opt out (1) conclusively determines the status of the Burnses' separate lawsuit; (2) resolves the Burnses' claims concerning the adequacy of notice, which are separate from the merits of the class action's settlement agreement; and (3) will be unreviewable on an appeal from final judgment, in that the district court's order effectively binds the Burnses to the terms of the settlement agreement. We therefore conclude that the challenged order amounts to a final decision and we exercise our jurisdiction pursuant to § 1291.
B. Standard of Review
We review the district court's denial of an opt-out motion for abuse of discretion. See Silber v. Mabon, 18 F.3d 1449, 1453 (9th Cir.1994); In re Piper Funds, Inc. (Institutional Gov't Income Portfolio Litig.), 71 F.3d 298, 304 (8th Cir.1995). "A court has abused its discretion when it 'based its decision on an erroneous conclusion of law or where there is no rational basis in evidence for the ruling.' " Mann v. Reynolds, 46 F.3d 1055, 1062 (10th Cir.1995) (quoting Wang v.
Free access — add to your briefcase to read the full text and ask questions with AI
Related
Cite This Page — Counsel Stack
132 F.3d 42, 1997 U.S. App. LEXIS 40043, 1997 WL 767763, Counsel Stack Legal Research, https://law.counselstack.com/opinion/burns-v-copley-pharmaceuticals-inc-ca10-1997.